Patent · US Expired

Pseudomonas aeruginosa antigens

US7517533B2 · kind B2 · utility

0Cited by
3References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2000
Grant dateApr 14, 2009
Priority date
Expiry dateDec 8, 2022

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Proteins derived from Pseudomonas aeruginosa are antigenic and are of use in the treatment, prophylaxis and diagnosis of P. aeruginosa infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.